Makabe et al. showed that baricitinib, a JAK1/2 inhibitor, alleviates inflammatory and neuropathic pain in a mouse arthritis model through modulation of IL-6/JAK/STAT3 and expression of colony-stimulating factor 1 (CSF-1) in neurons of DRG [50]. This evidence concerns the gene CSF1 and arthritic joint disease.